Klein Geltink, Ramon I. http://orcid.org/0000-0003-4610-3059
Edwards-Hicks, Joy http://orcid.org/0000-0002-9313-5718
Apostolova, Petya
O’Sullivan, David
Sanin, David E. http://orcid.org/0000-0003-0188-7267
Patterson, Annette E.
Puleston, Daniel J.
Ligthart, Nina A. M.
Buescher, Joerg M. http://orcid.org/0000-0002-6547-0076
Grzes, Katarzyna M.
Kabat, Agnieszka M. http://orcid.org/0000-0003-1916-5983
Stanczak, Michal
Curtis, Jonathan D.
Hässler, Fabian http://orcid.org/0000-0002-0038-9429
Uhl, Franziska M. http://orcid.org/0000-0001-8951-6289
Fabri, Mario
Zeiser, Robert
Pearce, Edward J. http://orcid.org/0000-0003-1001-9656
Pearce, Erika L. http://orcid.org/0000-0001-5592-5439
Funding for this research was provided by:
Sir Henry Wellcome Fellowship
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI110481)
Max-Planck-Gesellschaft
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA181125)
Article History
Received: 22 October 2019
Accepted: 1 July 2020
First Online: 3 August 2020
Competing interests
: E.L.P. is a SAB member of ImmunoMet Therapeutics, and E.L.P. and E.J.P. are founders of Rheos Medicines. The other authors declare no competing interests.